Similarly, CD93 (cg14928764) marks leukemic stem cells in MLL-rearranged AML and a therapy-resistant quiescent population in CML, while its inhibition reduces AML proliferation22–24. The gene discussed is KMT2A; the disease is acute myeloid leukemia.